360Dx

McGill University

May 05, 2016

C Diff Molecular Screening Strategy Reduces Incidence, Saves Money in Canadian Study

Premium

Nearly 8,000 patients participated in a screening study that used a PCR-based detection assay from Becton Dickinson, uncovering a 5 percent carrier rate.

Menu

McGill University

C Diff Molecular Screening Strategy Reduces Incidence, Saves Money in Canadian Study

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test